Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Intraperitoneal radioactive phosphate in early ovarian carcinoma: an analysis of complications

Journal Article · · International Journal of Radiation Oncology, Biology and Physics; (USA)
; ;  [1]
  1. Univ. of North Carolina School of Medicine, Chapel Hill (USA)
Intraperitoneal radioactive chromic phosphate was administered to 69 patients with Stage I and II ovarian carcinoma who had undergone comprehensive surgical staging. Intestinal obstruction requiring surgical intervention occurred in four patients and was the most severe complication. Abdominal pain was the most common post-therapy complaint. Attention to time and technique of drug administration could minimize complications.32 references.
OSTI ID:
5544331
Journal Information:
International Journal of Radiation Oncology, Biology and Physics; (USA), Journal Name: International Journal of Radiation Oncology, Biology and Physics; (USA) Vol. 20:5; ISSN 0360-3016; ISSN IOBPD
Country of Publication:
United States
Language:
English